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Chloroform extracts of Artemisia maciverae and Artemisia maritima (whole plants) were tested in vivo 
for anti-malarial activity in Swiss albino mice experimentally infected with chloroquine resistant 
Plasmodium berghei NK 65 at a dose of 100 mg/kg. The 2 plant extracts showed high anti-malarial 
activity. The parasitemia in the infected mice treated with the extracts were significantly reduced (P < 
0.05) when compared with the untreated negative control and the pre-treatment period (Day 0). The 
plant extracts were also screened for phytochemicals and secondary metabolites. Some 
phytochemicals like flavonoids, steroids, terpenoids, tannins, phlobatannins, alkaloids and 
anthraqinones were  detected in the two plant extracts. The anti-malarial activity of these extracts might 
be attributed to these phytochemicals/secondary metabolites. This study suggests that antiplasmodial 
activity of  Artemisia may be widely distributed within the genus. 
 





Malaria is one of the most prevalent infections in the 
world. It constitutes one of the main causes of death in 
much of the tropics. Malaria is caused by parasites of the 
genus Plasmodium, transmitted by female Anopheles 
mosquitoes. The most severe form of malaria is caused 
by Plasmodium falciparum and this species is 
responsible for over a million deaths each year (Breman,  
2001). In tropical and subtropical countries, malaria is the 
most important parasitic disease of man. A delay in 
diagnosis and treatment can have fatal consequences. 
The present global situation indicates a recent resur-
gence in the severity of the disease, that malaria could 
still be described as one of the most important diseases, 
with an annual incidence of 247 million clinically manifest 
cases and a death toll of 881,000 people (Martin et al., 
2004; Miller et al., 1994;More, 2002; David et al., 2004; 
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a matter of great concern throughout the world, especial-
ly in tropical and subtropical regions.  Though casualty is 
heaviest among children below the age of 5 years, the 
disease remains a major cause of death in all age groups 
in the affected geographical areas (Bickii et al., 2000). 
Part of the reason for the failure to control malaria is the 
emergence and spread of resistance to first-line anti-
malarial drugs, cross-resistance between the members of 
the limited number of drug families available and in some 
areas, multi-drug resistance (Bickii et al., 2000).  
A major breakthrough of the past decades has been 
the discovery by Chinese researchers of artemisinin 
(qinghaosu), an endoperoxide sesquiterpene lactone, as 
the active component of Artemisia annua, a herbal 
remedy used in Chinese folk medicine for over 2000 
years. This molecule and its oil-soluble artemether and 
arteether and water soluble artesunate semi-synthetic 
derivatives have shown excellent antiplasmodial efficacy 
in vivo and are being used increasingly, especially in 
combination with traditional anti-malarials  (Ernesto et al., 
2002). Few other species of Artemisia especially Artemi-sia 
absenthium   (Zafar   et    al.,    1990)    Artemisia    parvitora 




Table 1. Yield of A. maciverae and A. maritime extracts. 
 
Plants Solvents Weight of extracts (g) Yield (%) 
Artemisia maciverae Petroleum ether 1.39 ± 0.11 6.95 
Artemisia maciverae Chloroform 2.14 ± 0.08 10.70 
Artemisia maritima Petroleum ether 0.86 ± 0.04 4.30 




(Badam et al., 1988), Artemisia nilegarica and Artemisia 
japonica have also been shown to  have  antimalarial  ac- 
tivities (valecha et al.,1994).     
Artemisia maciverae Linn is a small herbaceous plant 
belonging to the family Asteraceae and is found in the 
northern part of Nigeria where it is locally known as 
“Tazargade” in Hausa. The Hausa people of northern 
Nigeria use this plant in treating malaria when it is boiled 
in water with lemon and red potash or soaked in local gin 
to treat malaria (Ene et al., 2008a). Our preliminary work 
suggested that this plant possesses high anti-malarial 
activity (Ene et al., 2008c). Another species known as 
Artemisia maritima as the name suggests is found in the 
riverine areas. It is locally known in Hausa as “Baba-
more”. and used in treating ailments like malaria and 
ulcer. This plant also belongs to the family Asteraceae. 
In Northern Nigeria, Artemisia maciverae and A. 
maritima are used interchangeably in the treatment of 
malaria. Therefore, these 2 species of Artemisia grown in 




MATERIALS AND METHODS 
 
Animal and animal husbandary 
   
Swiss albino mice weighing between 20 – 30 g were used for this 
study. The animals were obtained from Faculty of Pharmaceutical 
sciences, Ahmadu Bello University, Zaria and housed in the  animal 
house of Department of Biochemistry. The animals were fed ad 





The whole plants of A. maciverae and A. maritima used for this 
study were collected in Zaria and identified by a Taxanomist at the 
Herbarium Section of the Department of Biological Sciences, 
Ahmadu Bello University, Zaria. Zaria lies within Latitude 11°3’’N 





The whole plants of A. maciverae and A. maritima were air dried in 
the laboratory for about 2 weeks and ground into powder. 20 g each 
of the powdered samples was weighed into extraction timble and 
placed in a soxhlet extractor. The plant samples were extracted with 
petroleum ether for 6 h and with chloroform for another 6 h. The 
percentage yield of each of the plant sample was calculated (Table 
1). The chloroform extracts were then stored in the refrigerator at -
4°C, ready for use. 
Chloroquine resistant Plasmodium berghei parasite  
 
The chloroquine resistant P. berghei NK 65 used for this study was 
developed at the Post graduate Laboratory of the Department of 
Biochemistry of Ahmadu Bello University, Zaria using the method of 
Ene et al. (2008b). The parasite was maintained by sub-passaging 
into healthy mice every 5 - 7 days. 
The infection of the recipient mice was initiated by needle 
passage of the above mentioned parasite preparation, from the 
donor to healthy test animals via an intraperitoneal route (David et 
al., 2004; Peter  and Anatoli, 1998). Briefly P. berghei infected red 
blood cells were intraperitoneally injected into the mice from the 
blood diluted with Phosphate Buffered Saline (PBS) so that each 
0.2 ml that was injected per kg body weight of mice contained 
approximately 10 (Breiger, 2009) – 10 (Bickii et al., 2000) infected 
red blood cells. 
 
 
In vivo antiplasmodial tests 
 
Tests were performed using a 4 – day curative standard test (David 
et al., 2004; Peter  and Anatoli, 1998; WHO, 1980) and employing 
the chloroquine resistant Plasmodium berghei NK 65. 
The mice were divided into 5 groups of 6 mice each. The groups 
consisted of the 2 chloroform extract/treatment groups, artesunate 
standard control, chloroquine standard control and untreated 
control groups. All the mice were infected with the malaria parasites 
as described above. 
24 h after infecting the mice with the malaria parasites and para-
sitemia confirmed, the plant chloroform extracts were administered 
to the 2 test groups at a dose level of 100 mg/kg body weight (b.wt) 
for 4 days. Artesunate was administered to the standard control 
group at the standard dose of 1.6 mg/kg b.wt for 4 days. The 
untreated control groups were not treated. All drug administration 
was done through the intraperitoneal route. The dose level of 100 
mg/kg b.wt of the extract was selected from a preliminary study 
carried out in mice (Ene et al., 2008c). 
The extracts were dissolved to the indicated suitable dose level 
of 100 mg/kg in suspension, which requires total dissolution in 0.3% 
V/V Tween 80. Treatments were performed daily for 4 consecutive 
days starting 24 h after infection, receiving a total of 4 intraperi-
toneal doses(David et al., 2004).   
 
 
Estimation of parasitemia 
 
The parasitemia was monitored in all the groups starting from day 0 
to day 7 using thick and thin smears of blood films made from the 
tail vein of the mice(David et al., 2004; Ene et al., 2008b). The 
smears were stained with 10% Giemsa at pH 7.2 for 15 min and 
examined under the microscope at x100 to assess the level of 
parasitemia. The percentage parasitemia was calculated according 
to the method outlined by Iwalewa et al. (1997) as: Percentage 
parasitemia = (No of parasite in treated / No of parasite in control)  
x 100. 




Table 2. In vivo effect of crude chloroform extracts of Artemisia maciverae and Artemisia maritima on chloroquine resistant Plasmodium berghei NK 65 
 
 
All values were compared with each other on days 0, 3 and 7 at P = 0.05. 
n =  number of animals in a group. 




Phytochemical analysis of the chloroform extracts   
 
Phytochemical screening of the chloroform extracts of A. 
maciverae and A. maritima was carried out to determine 
the secondary metabolites present therein using standard 
procedures (Brain and Turner, 1975; Sofowara, 1982; 
Trease and Evans, 1983). The following were determined; 
flavonoids, cardiac glycosides, anthraquinones derivatives, 
carbohydrates, tannins, saponins, phlobatannins and 
alkaloids.   
 
 
Statistical analysis  
 
Results are expressed as mean + standard deviation and 






The percentage yield of extracts showed that for 
A. maciverae, more extract was produced with 
chloroform than with petroleum ether, but for A. 
mariitima, more extract was produced with petro-
leum ether than with chloroform.  
 Normal mice infected with chloroquine resistant 
P. berghei but not treated died within 4 - 7 days of 
infection, while infected mice treated with artesu-
nate (1.6 mg/kg b.w) survived (Table 2). On the 
other hand, all the infected mice treated with the 
chloroform extracts of A. maciverae and A. 
maritima showed clearance of the parasite to a 
higher level (that is, from 53 ± 0.07 to 27 ± 0.04 
for A. maciverae and from 50 ± 0.04 to 37 ± 0.06 
for A. maritima) when compared with the 
untreated controls (Table 2 ) 
A statistically significant difference (P < 0.05) 
was observed between the percentage parasite-
mia of the infected mice treated with the 
chloroform extract of A. maciverae and untreated 
infected mice (Table 2). The comparisons were 
made between days 0, 3 and 7. There was also a 
statistically significant difference (P < 0.05) bet-
ween the percentage parasitemia of the infected 
mice treated with the chloroform extract of A. 
maritima and the infected mice not treated (Table 
2). There was however no statistically significant 
difference (P > 0.05) observed when the infected 
mice treated with chloroquine was compared with 
untreated infected mice (Table 2). 
Though, the parasitemia was not completely 
cleared in the tests groups, it was drastically 
reduced  as stated in Table 2. However, this did 
not lead to their survival as they died within two 
weeks of extract administration (the parasitemia 
rose again  after  being  suppressed,  when  treat- 
ment with extract was withdrawn) as opposed to  
the group on artesunate which survived. 
In this study, parasitemia was confirmed in the 
infected mice after 24 h of infection with the 
chloroquine resistant P. berghei, while in infection 
with chloroquine sensitive P. berghei, parasitemia 
is usually confirmed after 72 h. This shows that 
the chloroquine resistant parasite is more virulent 
than the chloroquine sensitive parasite. 
The results of the phytochemical analysis of the 
extracts showing the presence of some secondary 
metabolites are presented in Table 3. The results 
show that the chloroform extract of A. maciverae 
contains flavonoids, steroids, terpenoids, tannins, 
phlobatannins and alkaloids, while the chloroform 
extract of A. maritima in addition to anthraquino-






There was in vivo anti-malarial activity observed 
with the chloroform extracts of the whole plants of 
A. maciverae and A. maritima. The anti-malarial 
activity observed with the chloroform extracts of 
these plants might be attributed to the presence of 
some  active  ingredients/ secondary   metabolites 
 
Drug 
n Drug dose (mg/kg) 
Average parasitemia (%) 
Day 0 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Artemisia maciverae 6 100 0.53±0.07c 0.60±0.09 0.63±0.03 0.43±0.06a 0.30±0.04 0.30±0.04 0.27±0.04 0.27±0.04b 
Artemisia maritime 6 100 0.50±0.04c 0.60±0.01 0.60±0.07 0.57±0.08 0.40±0.05 0.40±0.05 0.37±0.06 0.37±0.06b 
Artesunate standard (control) 6 1.6 0.43±0.03c 0.13±0.04 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 
Chloroquine standard (Control)  6 25 0.49±0.04c 3.67±0.10 4.17±0.10 7.97±0.17bc 7.93±0.32 8.03±0.62 8.03±0.62 8.03±0.62ef 
Untreated control 6  0.50±0.07c 2.37±0.17 4.27±0.12 6.90±0.35bc 7.93±0.53 8.20±0.60 8.20±0.60 8.20±0.60ef 




Table 3. Phytochemical screening of chloroform extracts of A. maciverae and A. maritime. 
 
Phytochemical Specific test A. maciverae A. maritima 
Flavonoids Shinoda’s test - - 
 Sodium hydroxide test - - 
 Lead acetate test + + 
 Ferric chloride test + + 
Cardiac glycosides Lieberman Burkard test + + 
 Salkowskii test + + 
 Killer-kilianin test + + 
Anthraquinones derivatives Test for combined anthraquinones 





Carbohydrates Molisch reagent test + + 
 Barfoed’s test + - 
 Fehling’s test + + 
 Test for combined reducing sugar + + 
Tannins Test with ferric chloride solution + - 
Saponins Frothing test - - 
Phlobatannins Test with dilute hydrochloric acid + - 














in these plants (Peter  and Anatoli, 1998). The chloroform 
extract of A. maciverae was found to contain flavonoids, 
steroids, terpenoids, tannins, phlobatannins and 
alkaloids, while in the chloroform extract of A. maritima, 
flavonoids, steroids, terpenoids, anthraquinones and 
alkaloids were found to be present. The presence of 
these phytochemicals in these plants, especially alkaloids 
and terpenoids (Hoet et al., 2004) might be responsible 
for the anti-malarial activity exhibited by them. This can 
be supported by the studies carried out by Badman et al. 
(1988) and Klayman (1985) which show conclusively that 
artemisinin, the antipyretic principle/ingredient of the plant 
A. annua, possess anti-malarial activity. This artemisinin 
belongs to sesquiterpene lactone (Ubaleeet al., 1999). 
In a similar study carried out by other workers 
(Ajaiyeoba et al., 1999) on two Nigerian plants belonging 
to the family simaroubaceae, Quassia amara L. and 
Quassia undulata  anti-malarial properties were demon-
strated when hexane and methanol extracts at a dose of  
100 mg/kg body weight (b.wt) of mouse showed 
significant anti-malarial activities in the 4 – day suppres-
sive in vivo anti-malarial assay. Thus is in support of the 
anti-malarial activity observed with the chloroform 
extracts of the whole plants of A. maciverea and A. 
maritima at a dose concentration of 100 mg/kg b.wt in 
this study. 
In another study (Dikasson et al., 2006) on the plant  
Asparagus afrcicanus Lam using the hydroalcoholic 
extracts in vivo in P. berghei infected mice, the extracts 
from the roots and aerial parts of the plant were observed 
to inhibit P. berghei parasitemia in the Swiss albino mice 
by 46.1 and 40.7% respectively. This is also in support of 
the anti-malarial activity observed with the two plant 
extracts in this study. It is likely that specific alkaloids and 
terpenoids are present in all these plants studied by other 
workers to show their anti-malarial activities. 
A. maciverae showed more anti-malarial activity than A. 
maritima in this study. This might be because A. 
maciverae contain specific alkaloids and terpenoids 
which have better anti-malarial activities compared to A. 
maritime 
Other workers (valecha et al.,1994) have studied the 
anti-malarial activity of some members of the genus 
Artemisia. Their results show that the ethanol extracts of 
the aerial parts of A. Japonica and A. nilegarica inhibited 
parasitemia at 87.5 and 84.4% respectively. The 
parasitemia was not completely cleared by these crude 
ethanol extracts of these plants. This is in agreement with 
the results obtained with the crude chloroform extracts of 
A. maciverae and A. maritima in this study. The crude 
chloroform extracts of the whole plants of A. maciverae 
and A. maritima inhibited parasitemia at 73.0 and 63.0%, 
respectively. Parasitemia was not completely cleared. 
Mice infected with the parasite but not treated, showed 
fulminant parasitemia which resulted in death 4 – 7 days 
later. This is in  agreement  with  the  work  of  Ene  et  al.  









From this study, it can be concluded that the chloroform 
extracts of A. maciverae and A. maritima (whole plants) 
possess significant suppressive effects on P. berghei 
infection in Swiss albino mice. Therefore, the chloroform 
extracts of these two plants are currently under study to 
establish the active ingredient responsible and its 
quantitative distribution using bioassay guided isolation. 
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